Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours

C. Twelves, K. Hoekman, A. Bouwman, J.B. Vermorken, A. Anthoney, J. Smyth, C. van Kesteren, J.H. Beijnen, J. Uiters, J. Wanders, J. Gomez, C. Guzman, J.M. Jimeno, A.R. Hanauske

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1842-1851
Number of pages10
JournalEuropean Journal of Cancer
Publication statusPublished - 2003


  • Farmacie/Biofarmaceutische wetenschappen (FARM)
  • Farmacie(FARM)

Cite this